Mediterranean Diet and Time-Restricted Feeding in Ulcerative Colitis Remission
MEDITIME-UC
1 other identifier
interventional
45
1 country
1
Brief Summary
This study will evaluate whether a 12-week dietary intervention can improve gut health, inflammation, and quality of life in adults with ulcerative colitis in remission. Participants will be randomly assigned to one of three groups: a Mediterranean diet, a Mediterranean diet combined with time-restricted feeding (eating within an 8-hour window each day), or standard dietary advice. The Mediterranean diet emphasizes fruits, vegetables, whole grains, legumes, nuts, olive oil, and fish, while limiting processed foods and red meat. The main outcome will be changes in short-chain fatty acids in stool samples, which are markers of gut health. Additional outcomes include changes in inflammation markers, gastrointestinal symptoms, and quality of life. The results of this study may help identify effective dietary strategies to support patients with ulcerative colitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 10, 2026
CompletedFirst Submitted
Initial submission to the registry
April 22, 2026
CompletedFirst Posted
Study publicly available on registry
August 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
August 7, 2026
August 1, 2026
1 year
April 22, 2026
August 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in fecal short-chain fatty acid (SCFA) levels
Fecal SCFA concentrations will be measured using gas chromatography and expressed as total and individual SCFA levels.
Baseline to 12 weeks
Secondary Outcomes (1)
Change in fecal calprotectin
Baseline to 12 weeks
Study Arms (3)
Mediterranean Diet
EXPERIMENTALParticipants will receive individualized nutritional counseling to follow a Mediterranean diet, emphasizing fruits, vegetables, whole grains, legumes, nuts, olive oil, and fish, while limiting red meat and ultra-processed foods.
Mediterranean Diet + Time-Restricted Feeding
EXPERIMENTALParticipants will follow a Mediterranean diet combined with time-restricted feeding (16:8), consisting of an 8-hour eating window and a 16-hour fasting period
Standard Diet
ACTIVE COMPARATORParticipants will receive standard dietary counseling based on current clinical guidelines for ulcerative colitis.
Interventions
Participants will receive individualized nutritional counseling to follow a Mediterranean diet, emphasizing high intake of fruits, vegetables, whole grains, legumes, nuts, olive oil, and fish, and reduced consumption of red meat and ultra-processed foods. Dietary plans will be tailored to individual energy requirements.
Participants will follow a time-restricted feeding protocol (16:8), consisting of a daily 16-hour fasting period and an 8-hour eating window (12:00-20:00). During the eating window, participants will consume meals based on Mediterranean diet guidelines, with individualized dietary counseling to ensure adequate nutritional intake.
Participants will receive standard dietary counseling based on current clinical guidelines for ulcerative colitis. This includes general recommendations for a balanced diet without specific emphasis on Mediterranean dietary patterns or time-restricted feeding.
Eligibility Criteria
You may qualify if:
- Adults aged 18 to 60 years
- Diagnosis of ulcerative colitis
- Clinical remission for at least 6 months
- Fecal calprotectin \< 250 µg/g in the last 3 months
- Daily eating window ≥ 11 hours
You may not qualify if:
- Active ulcerative colitis
- History of gastrointestinal surgery
- Liver or kidney disease
- Pregnancy
- Eating disorders
- Use of supplements (protein, antioxidants, probiotics)
- Current restrictive diets (vegetarian, vegan, gluten-free, low-FODMAP)
- High levels of physical activity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pontificia Universidad Católica de Chile
Santiago, Santiago Metropolitan, Chile
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Nutritionist, PhD, MSc, Department of Nutrition and Dietetics, School of Health Sciences, Pontificia Universidad Católica de Chile
Study Record Dates
First Submitted
April 22, 2026
First Posted
August 7, 2026
Study Start
April 10, 2026
Primary Completion (Estimated)
April 10, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
August 7, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to privacy and ethical considerations. Data contain sensitive health information, and consent for data sharing was not explicitly obtained from participants. Aggregated results will be made available through scientific publications.